Nature Medicine

Published by: Nature Publishing Group  

People

  1. Levine
    Levine
  2. Sadelain
    Sadelain
  3. Abdel-Wahab
    Abdel-Wahab
  4. De Stanchina
    De Stanchina
  5. Berger
    Berger
  6. Ladanyi
    Ladanyi
  7. Massague
    Massague
  8. Sawyers
    Sawyers
  9. Van Den Brink
    Van Den Brink
  10. Wolchok
    Wolchok

Groups

  1. GSK Faculty (107)
  2. Department of Medicine (105)
  3. Sloan Kettering Institute Faculty (67)
  4. Center for Hematologic Malignancies (58)
  5. Hematologic Malignancies, Division of (57)
  6. Sloan Kettering Institute Postdocs (54)
  7. Human Oncology and Pathogenesis Program (53)
  8. Solid Tumor Oncology Division (48)
  9. Executive Committee, Center for Hematologic Malignancies (34)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (33)
Search Within
Formats
  1. Journal Article (162)
  2. Research Letter (12)
  3. Review (4)
  4. Correspondence (3)
  5. Editorial (3)
Groups
  1. GSK Faculty (107)
  2. Department of Medicine (105)
  3. Sloan Kettering Institute Faculty (67)
  4. Center for Hematologic Malignancies (58)
  5. Hematologic Malignancies, Division of (57)
  6. Sloan Kettering Institute Postdocs (54)

More Groups

People
  1. Ross Levine (12)
  2. Michel Sadelain (10)
  3. Omar Abdel-Wahab (9)
  4. Elisa De Stanchina (8)
  5. Charles Sawyers (7)
  6. Jedd Wolchok (7)

More People

Years
  1. 2023 (3)
  2. 2022 (17)
  3. 2021 (7)
  4. 2020 (15)
  5. 2019 (15)
  6. 2018 (11)

More Years

Publishers
  1. Nature Publishing Group (184)

Results (184)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: A randomized, perioperative phase 1 trial
    Journal Article

    Mellinghoff, I. K.; Lu, M.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga-Romany, I.; Peters, K. B.; Ellingson, B. M.; Rosenblum, M. K.; Chun, S.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Prevalence of smoldering multiple myeloma based on nationwide screening
    Journal Article

    Thorsteinsdóttir, S.; Gíslason, G. K.; Aspelund, T.; Rögnvaldsson, S.; Óskarsson, J. Þ; Sigurðardóttir, G. Á; Þórðardóttir, Á R.; Viðarsson, B.; Önundarson, P. T.; Agnarsson, B. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: Phase 1 UNIVERSAL trial interim results
    Journal Article

    Mailankody, S.; Matous, J. V.; Chhabra, S.; Liedtke, M.; Sidana, S.; Oluwole, O. O.; Malik, S.; Nath, R.; Anwer, F.; Cruz, J. C.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
    Journal Article

    Chatila, W. K.; Kim, J. K.; Walch, H.; Marco, M. R.; Chen, C. T.; Wu, F.; Omer, D. M.; Khalil, D. N.; Ganesh, K.; Qu, X.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: Phase 1 trial interim results
    Journal Article

    Palmer, C. D.; Rappaport, A. R.; Davis, M. J.; Hart, M. G.; Scallan, C. D.; Hong, S. J.; Gitlin, L.; Kraemer, L. D.; Kounlavouth, S.; Yang, A. R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • PIK3CA hotspot mutation generates a shared neoantigen targetable by TCR gene therapy
    Editorial

    Klebanoff, C. A.; Chandran, S. S.
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Ensuring remote diagnostics for pathologists: An open letter to the US Congress
    Correspondence

    Lennerz, J. K.; Pantanowitz, L.; Amin, M. B.; Eltoum, I. E.; Hameed, M. R.; Kalof, A. N.; Khanafshar, E.; Kunju, L. P.; Lazenby, A. J.; Montone, K. T.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: A phase 2 trial
    Journal Article

    Carvajal, R. D.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L.; Nathan, P.; Hamid, O.; Piulats, J. M.; Rioth, M.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab for resectable non-small cell lung cancer: An open-label, single-arm phase II trial
    Journal Article

    Chaft, J. E.; Oezkan, F.; Kris, M. G.; Bunn, P. A.; Wistuba, I. I.; Kwiatkowski, D. J.; Owen, D. H.; Tang, Y.; Johnson, B. E.; Lee, J. M.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save

    • Nature Medicine – authorized name for:

    Name ISSN / ISBN Publisher
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1546-170X Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 10788956 2022, The Author(s), Under Exclusive Licence To Springer Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 10788956 2022, Springer Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 10788956 2021, Springer Nature America, Inc
    Nature Medicine 10788956 2021, The Author(s), Under Exclusive Licence To Springer Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 10788956 Unknown
    Nature Medicine 10788956 2020, The Author(s), Under Exclusive Licence To Springer Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Co
    Nature Medicine 10788956 2023, The Author(s), Under Exclusive Licence To Springer Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1546-170X Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature America, Inc
    Nature Medicine 10788956 2022, The Author(s)
    Nature Medicine 1078-8956 Nature America, Inc
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Publishing Group
    Nature Medicine 1078-8956 Nature Research